Cachexia: clinical features when inflammation drives malnutrition

Area of Science:

• Clinical Medicine
• Nutrition Science
• Oncology

Background:

• Cachexia is a serious syndrome marked by muscle loss, negatively impacting patient quality of life, morbidity, and mortality.
• It is triggered by disease-associated inflammatory responses and is considered a continuum requiring effective staging.
• Early detection and intervention are crucial for managing cachexia.

Purpose of the Study:

• To highlight the importance of a robust staging system for cachexia.
• To emphasize the role of nutritional monitoring and intervention in patient outcomes.
• To discuss the impact of cachexia on cancer patients undergoing chemotherapy.

Main Methods:

• Review of existing literature on cachexia staging systems.
• Analysis of clinical trial data, particularly in cancer patients.
• Examination of the physiological mechanisms underlying cachexia and potential nutritional interventions.

Main Results:

• A five-stage classification system, based on BMI and weight loss severity, is more predictive of clinical outcomes than previous systems.
• Cachexia developing during chemotherapy significantly impacts survival more than baseline weight loss.
• Nutritional interventions, including specific nutrients and sustained hyperaminoacidaemia, can overcome anabolic resistance and revert catabolism.

Conclusions:

• Routine monitoring of nutritional status is essential for early cachexia diagnosis.
• Improved nutritional status and body weight preservation during or after chemotherapy correlate with longer survival in cancer patients.
• Effective staging and timely nutritional interventions are key to managing cachexia and improving patient prognosis.